Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;100(10):774-780.
doi: 10.1055/a-1578-0281. Epub 2021 Sep 1.

[Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021]

[Article in German]
Susanne Wiegand  1 , Gunnar Wichmann  1 , Andreas Dietz  1
Affiliations

[Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021]

[Article in German]
Susanne Wiegand et al. Laryngorhinootologie. 2021 Oct.

Abstract
in English, German

The therapeutic options in head and neck oncology are rapidly developing, especially through the use of checkpoint inhibitors. Currently, numerous therapeutic studies with new molecular targets or new drug combinations are underway in patients with head and neck cancer. The most important results of the studies presented at the ASCO Annual Meeting 2021 on head and neck cancer will be presented in this paper.

Aktuell entwickeln sich die therapeutischen Möglichkeiten im Gebiet der Kopf-Hals-Onkologie, v. a. durch den Einsatz von Checkpoint-Inhibitoren, rasch weiter. Momentan werden zahlreiche Studien zur medikamentösen Therapie von Kopf-Hals-Karzinomen mit neuen molekularen Targets bzw. neuen Medikamentenkombinationen durchgeführt. Die wichtigsten Ergebnisse der Studien, die bei der ASCO-Jahrestagung 2021 zu Kopf-Hals-Karzinomen vorgestellt wurden, sollen in dieser Arbeit vorgestellt werden.

PubMed Disclaimer

Conflict of interest statement

Wiegand: Wissenschaftliche Präsentationen bzw. Mitarbeit in Advisory Boards: Astra Zeneca, Brisol-Myers Squibb, Merck Serono, MSD, Nanobiotix, Roche, Sanofi GenzymeWichmann: keineDietz: Wissenschaftliche Präsentationen bzw. Mitarbeit in Advisory Boards: Merck Serono, Roche, Astra Zeneca, MSD, BMS, Sanofi, Novartis, Norgine, GSK, Nanobiotix Forschungsunterstützung: Roche, Merck Serono, MSD

LinkOut - more resources